# Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis

> **NCT06652464** · — · COMPLETED · sponsor: **Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital** · enrollment: 90 (actual)

## Conditions studied

- Disease Activity
- Remission of Ulcerative Colitis
- Ulcerative Colitis Flare

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06652464
- **Lead sponsor:** Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-15
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06652464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06652464, "Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06652464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*